Core Viewpoint - InnovAge Holding Corp. has appointed Pavithra Mahesh and Sean Traynor to its Board of Directors, expanding the board from nine to eleven members, which is expected to enhance strategic perspectives and support the company's growth in the PACE model of care [1][2]. Group 1: Board Appointments - Pavithra Mahesh will serve as a Class III director and a member of the Quality and Compliance Committee [1] - Sean Traynor will serve as a Class I director and a member of the Compensation, Nominating and Governance Committee [1] - Both appointees have prior experience on the InnovAge Board, with Mahesh initially joining in 2020 and Traynor in 2015 [2][3] Group 2: Experience and Background - Pavithra Mahesh is currently a Principal at Apax Partners and has a background in healthcare services and information technology from Goldman Sachs [2] - Sean Traynor is a General Partner at Welsh, Carson, Anderson & Stowe and has extensive experience in the healthcare sector, serving on multiple boards [3] Group 3: Company Overview - InnovAge is a leader in managing care for frail, dual-eligible seniors through the PACE model, aiming to improve care quality while reducing high-cost care utilization [4] - As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states [4]

Core Viewpoint - InnovAge Holding Corp. is set to release its fiscal second quarter financial results for 2026 on February 3, 2026, after market close, followed by a conference call to discuss the results [1]. Group 1: Financial Results Announcement - The company will announce its 2026 fiscal second quarter financial results on February 3, 2026, after market close [1]. - A conference call to review the financial results will take place at 5 p.m. E.T. on the same day [1]. Group 2: Conference Call Details - A live audio webcast of the conference call will be available on the company's website [2]. - A replay of the call will be accessible shortly after the completion of the call for on-demand listening [2]. - Participants are encouraged to dial in fifteen minutes before the scheduled start time [2]. Group 3: Company Overview - InnovAge is a market leader in managing care for high-cost, frail, and predominantly dual-eligible seniors through the PACE program [3]. - The company's mission is to enable older adults to age independently in their homes for as long as safely possible [3]. - As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states [3].

Core Insights - InnovAge is positioned as a strong investment opportunity due to its unique value-based care model and recent internal transformations [2][3] - The company aims to demonstrate its stability and performance in a challenging healthcare environment, particularly for Medicare and Medicaid [3] Company Overview - InnovAge has undergone significant evolution over the past several years, leading to a unique inflection point in its history [2] - The company is described as a scaled, vertically integrated platform that has focused on stabilizing and rebuilding its operations [3]

InnovAge Conference Call Summary Company Overview - **Company**: InnovAge - **Industry**: Healthcare, specifically focused on value-based care for dual eligibles (Medicare and Medicaid beneficiaries) [2][3] Core Business Model - InnovAge operates a vertically integrated payer-provider platform delivering personalized value-based care to medically and socially complex dual eligibles [3] - The company takes full financial accountability for outcomes and costs across the full scope of Medicare and Medicaid services, with an average premium of approximately $9,500 per participant per month [4] Operational Highlights - InnovAge operates 20 centers across six states, with two additional centers under development, serving nearly 8,000 participants [5] - The company has invested heavily in scalable technology and operating infrastructure, enhancing payer-grade utilization management capabilities [5] - The focus is now on optimizing the platform for responsible growth, expanding margins, and leveraging data and technology [6] Financial Performance - In Q1 FY2026, InnovAge achieved a 7.5% adjusted EBITDA margin and positive operating cash flow on a trailing 12-month basis [13] - The company expects continued growth and margin expansion, with long-term potential for adjusted EBITDA margins around 10% [14] Market Position and Growth Strategy - InnovAge is the only PACE organization with significant scale and geographic diversification, positioning it as a partner of choice for health systems and communities [12] - The company is exploring joint ventures with local health systems to enhance care coordination and expand access [12] - There is a significant market opportunity for PACE programs, which remain underpenetrated, particularly among dual eligibles [11] Regulatory Environment - There is growing bipartisan recognition of the value that PACE delivers, which supports sustained growth of PACE programs [11] - InnovAge is preparing for potential changes in Medicare risk adjustment models and is taking a conservative approach to manage associated risks [41][42] Technology and Operational Improvements - Recent investments include the rollout of the Epic EMR and Oracle financial platform, aimed at improving quality, compliance, and efficiency [21][22] - The company is leveraging AI to enhance clinical decision-making and reduce costs [23][24] Enrollment and Acuity Management - InnovAge is balancing enrollment growth with acuity mix to ensure appropriate risk reflection and economic viability [27][28] - The company has successfully rebalanced its participant mix to maintain economic leverage while prioritizing patient care [28] De Novo and Acquisition Strategy - InnovAge is evaluating both De Novo center development and bolt-on acquisitions, with a focus on markets with large and growing senior populations [29][30] - The company has identified opportunities to acquire subscale PACE programs that are struggling to meet expectations [31] Lessons Learned and Future Outlook - Key lessons from recent De Novo launches emphasize the importance of strong community relationships and awareness of the PACE model [33][35] - InnovAge is well-positioned to leverage its investments and operational improvements to deliver quality care and create value for stakeholders [45] Conclusion - InnovAge's unique integrated model, operational discipline, and strategic investments position it for continued growth and success in the evolving healthcare landscape [15][45]

d JPM Healthcare Conference January 2026 2 Company highlights Disclaimer Cautionary Note Regarding Forward-Looking Statements: These presentation materials contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, including, without limitation, estimates of and goals for future operating, financial and tax performance and results, as well as the expected execution and effect of our business str ...

Core Insights - InnovAge Holding Corp. is a leader in providing comprehensive healthcare programs for frail, predominantly dual-eligible seniors through the PACE model [1][2] - The CEO, Patrick Blair, will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 [1] Company Overview - InnovAge's mission is to enable older adults to age independently in their homes for as long as safely possible [2] - The company serves approximately 7,890 participants across 20 centers in six states as of September 30, 2025 [2] - InnovAge's patient-centered care model aims to improve care quality while reducing over-utilization of high-cost care settings [2]

Core Insights - InnovAge Holding Corp. (INNV) shares increased by 7.8% to close at $5.82, driven by higher trading volume and an overall gain of 11.6% over the past four weeks [1][2] Financial Performance - In fiscal Q1 2025, InnovAge reported total revenues of $236.1 million, reflecting a year-over-year increase of approximately 15.1% [2] - The company achieved a net income of $7.7 million, a significant turnaround from a net loss of $5.7 million in the same quarter last year [2] Earnings Expectations - InnovAge is projected to report quarterly earnings of $0.04 per share, indicating a year-over-year growth of 140% [3] - Expected revenues for the upcoming quarter are $228.16 million, which represents a 9.2% increase from the previous year [3] Earnings Estimate Revisions - The consensus EPS estimate for InnovAge has been revised 20% higher in the last 30 days, suggesting a positive trend that typically correlates with stock price appreciation [4] - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [4] Industry Context - InnovAge is part of the Zacks Medical Services industry, where another company, Danaher (DHR), saw a 1% increase in its stock price, closing at $228.53, with a 2.3% return over the past month [4] - Danaher has a Zacks Rank of 4 (Sell), with its EPS estimate remaining unchanged at $2.14 compared to the previous year [5]

Summary of InnovAge FY Conference Call - November 14, 2025 Industry Overview - The discussion revolves around the aging in place healthcare model, focusing on the challenges and opportunities in providing care for the elderly in their homes rather than in institutional settings [4][69]. Key Points and Arguments Aging Population and Healthcare System - The healthcare system must adapt to accommodate over 30 years of post-retirement life as people live longer [4][69]. - There is a need to address inefficiencies in the current aging care system to make longevity economically sustainable [4][69]. Inefficiencies in Home Care - Pippa Schulman from DispatchHealth highlights the complexity of delivering care at home, noting that reimbursement structures are confusing and do not support home-based care adequately [7][8]. - Joe Camorra from SCAN Health Plan emphasizes the increasing complexity of matching resources to the needs of aging patients, leading to administrative waste [9][10]. Role of Private Capital - The panelists agree on the importance of private capital in scaling aging-in-place healthcare models, as the not-for-profit sector struggles to drive models to scale [16][17]. - Private funding is seen as essential for innovation and rapid deployment of healthcare solutions [16][18]. Technology and AI in Home Care - AI is viewed as a tool to improve logistics and patient care by better matching patients with the right resources and care plans [25][30]. - The panelists discuss the potential of AI to streamline operations and enhance patient interactions, allowing clinicians to focus more on care rather than administrative tasks [30][32]. Trust and Patient Engagement - Building trust with patients is crucial, as many elderly individuals feel overwhelmed by the healthcare system and require time to establish rapport with their caregivers [36][37]. - The need for personalized care that respects the individual’s preferences and functional status is emphasized [91]. Future Innovations - The panelists express optimism about the future of aging in place, anticipating more coordinated care models and simplified payment structures [60][61]. - There is a call for a permanent payment model for home-based care to facilitate better service delivery [69]. Challenges in the PACE Model - The PACE (Program for All-Inclusive Care for the Elderly) model faces growth limitations due to geographic accessibility and competition from other care models [95][96]. - The need for policy changes to promote coordinated care programs like PACE is highlighted [95]. Other Important Insights - The discussion touches on the importance of socialization and community engagement for the elderly, as loneliness is a significant issue for aging individuals [66][70]. - The panelists stress the need for a user-centered design in healthcare technology to cater to a diverse elderly population [87][88]. This summary encapsulates the key discussions and insights from the InnovAge FY Conference Call, focusing on the challenges and opportunities in the aging in place healthcare model.

Core Insights - InnovAge Holding Corp and Tampa General Hospital have formed a joint venture to enhance access to the Program of All-inclusive Care for the Elderly (PACE) in the Tampa Bay region, aiming to provide comprehensive healthcare to frail seniors [1][2][3] InnovAge Overview - InnovAge is a leader in managing care for high-cost, frail seniors, focusing on enabling them to age independently at home. As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states [4] Tampa General Hospital Overview - Tampa General Hospital is a 1,529-bed not-for-profit academic health system, recognized as one of the largest hospitals in America. It is the highest-ranked hospital in Tampa Bay according to U.S. News & World Report's 2025-2026 Best Hospitals [5][6] Partnership Goals - The partnership aims to expand access to PACE's person-centered care model, which allows seniors to live independently while receiving a full range of medical, social, and in-home support, often at little to no cost for dual-eligible individuals under Medicaid and Medicare [2][3] Community Impact - The collaboration emphasizes the importance of supporting caregivers through education and respite services, thereby empowering families alongside their loved ones. The partnership also includes community support initiatives, such as donations to local organizations [3]

Core Viewpoint - InnovAge Holding Corp. reported quarterly earnings of $0.06 per share, significantly beating the Zacks Consensus Estimate of $0.01 per share, and showing an improvement from a loss of $0.04 per share a year ago, indicating a strong earnings surprise of +500.00% [1] Financial Performance - The company posted revenues of $236.11 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.01%, and showing an increase from $205.14 million in the same quarter last year [2] - Over the last four quarters, InnovAge has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - InnovAge shares have increased approximately 20.6% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] Future Outlook - The company's earnings outlook will be crucial for determining the sustainability of its stock price movement, with current consensus EPS estimates at $0.04 for the coming quarter and $0.24 for the current fiscal year [4][7] - The estimate revisions trend for InnovAge was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical Services industry, to which InnovAge belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting that the industry outlook could materially impact stock performance [8]